EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia

Emanuele Martorana iD, Gabriele Raciti iD, Raffaella Giuffrida iD, Elena Bruno iD, Vincenzo Ficarra, Giuseppe Mario Ludovico, Nazareno Roberto Suardi iD, Nunzio Iraci iD, Loredana Leggio iD, Benedetta Bussolati iD, Cristina Grange iD, Aurelio Lorico iD und 2 weitere

Cells · 2024

DOI: 10.3390/cells13151286 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Emanuele Martorana und 13 weiteren Autor:innen. Beteiligte Einrichtung: IOM Ricerca Srl, Viagrande, 95029 Catania, Italy. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Biomarkers, Tumor, Extracellular Vesicles. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell'Università e della Ricerca (MUR), Italian Ministry of University and Research (MUR).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prostate cancer is the second most common cancer in males worldwide, and its incidence is rising. Early detection is crucial for improving the outcomes, but the current screening methods have limitations. While prostate-specific antigen (PSA) testing is the most widely used screening tool, it has poor specificity, leading to a high rate of false positives and unnecessary biopsies. The existing biopsy techniques are invasive and are associated with complications. The liquid biopsy methods that analyze the biomarkers in blood or other bodily fluids offer a non-invasive and more accurate alternative for detecting and characterizing prostate tumors.

Methods

Here, we present a novel liquid biopsy method for prostate cancer based on the identification of specific proteins in the extracellular vesicles isolated from the blood of patients with prostate cancer.

Results

We observed that a specific combination of sEV proteins is a sensitive indicator of prostate cancer. Indeed, we found that the number of clusters expressed by specific combinations of either intra-vesicular (STAT3 and CyclinD1) or surface proteins (ERBB3, ALK, and CD81) allowed us to significantly discriminate the patients with prostate cancer from the individuals with hyperplasia.

Conclusion

This new liquid biopsy method has the potential to improve prostate cancer screening by providing a non-invasive and more accurate diagnostic tool.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsBiomarkers, TumorExtracellular VesiclesMaleHumansLiquid BiopsyDiagnosis, DifferentialProstatic HyperplasiaAgedMiddle Aged

Stichwörter der Autor:innen

biomarkersextracellular vesiclesliquid biopsyprostate cancer

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • IOM Ricerca Srl, Viagrande, 95029 Catania, Italy.
  • Department of Biomedical, Dental and Morphological and Functional Imaging Sciences, University of Messina, 98122 Messina, Italy.
  • Department of Physic and Astronomy "Ettore Majorana", University of Catania, 95123 Catania, Italy.
  • Azienda Ospedaliera Policlinico Universitario "G. Martino", Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva, 98124 Messina, Italy.
  • Ospedale Generale Regionale "F. Miulli", Divisione di Urologia, Acquaviva Delle Fonti, 70021 Bari, Italy.
  • Azienda Ospedaliera Policlinico Universitario Di Genova, Divisione di Urologia, 16132 Genova, Italy.

ORCID-Profile: Emanuele Martorana, Gabriele Raciti, Raffaella Giuffrida, Elena Bruno, Nazareno Roberto Suardi, Nunzio Iraci, Loredana Leggio, Benedetta Bussolati, Cristina Grange, Aurelio Lorico, Stefano Forte

Förderung

  • Ministero dell'Università e della Ricerca (MUR)
  • Italian Ministry of University and Research (MUR)

Zitieren

APA

Martorana, E., Raciti, G., Giuffrida, R., Bruno, E., Ficarra, V., Ludovico, G. M., Suardi, N. R., Iraci, N., Leggio, L., Bussolati, B., Grange, C., Lorico, A., Leonardi, R., & Forte, S. (2024). A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia. Cells. https://doi.org/10.3390/cells13151286

Vancouver

Martorana E, Raciti G, Giuffrida R, Bruno E, Ficarra V, Ludovico GM, et al. A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia. Cells. 2024. doi:10.3390/cells13151286

BibTeX
@article{Martorana2024,
  author = {Martorana, Emanuele and Raciti, Gabriele and Giuffrida, Raffaella and Bruno, Elena and Ficarra, Vincenzo and Ludovico, Giuseppe Mario and Suardi, Nazareno Roberto and Iraci, Nunzio and Leggio, Loredana and Bussolati, Benedetta and Grange, Cristina and Lorico, Aurelio and Leonardi, Rosario and Forte, Stefano},
  title = {A Novel Liquid Biopsy Method Based on Specific Combinations of Vesicular Markers Allows Us to Discriminate Prostate Cancer from Hyperplasia},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells13151286}
}
Kostenlos starten →